RTsafe and TheraPanacea join hands towards supporting an AI-based research and clinical trial project aiming to improve survival of brain tumor patients through personalized radiation treatment.

RTsafe and TheraPanacea join hands towards supporting an AI-based research and clinical trial project aiming to improve survival of brain tumor patients through personalized radiation treatment.

Athens, Greece – Paris, France 11 January 2021 TheraPanacea, Institut Gustave Roussy, AP-HP Pitié Salpétrière, Institut de Cancérologie Strasbourg Europe, and GE-Healthcare recently announced a promising collaboration to provide an AI-powered solution to optimize the response to radiation treatment of patients with brain tumors (glioblastoma) via a personalized treatment approach (link to the announcement). Leveraging […]

RTsafe & Mercurius Health launch a collaboration to promote safe and auditable SRS and SBRT/SABR treatments.

Athens, Greece   –   November 9, 2020 RTsafe and Mercurius Health today proudly announced that they have launched a collaboration based on promoting safe and auditable stereotactic treatments. The partnership is rooted in the implementation EURATOM directive 2013/59, with a focus on end-to-end SRS/SBRT QA, using RTsafe’s Prime®, Spine and Pseudopatient® services. The two companies offer […]